Literature DB >> 2197634

Diet and nasopharyngeal carcinoma.

M C Yu1.   

Abstract

Nasopharyngeal carcinoma (NPC) is a disease with a remarkable racial and geographical distribution. It is very rare (incidence of less than 1 per 100,000 person-years) in most parts of the world and only a handful of populations are known to deviate from this low-risk profile, which include people of southern China, Eskimos and other natives of the Arctic region, natives of southeast Asia, and the mainly Arab populations of north Africa and Kuwait. There is now convincing evidence implicating dietary factors as the primary cause of NPC among Chinese. A series of case-control studies conducted in various Chinese populations with distinct risks of NPC, ranging from the very high-risk Cantonese to the relatively low-risk Northern Chinese, have suggested that ingestion of salted fish and other kinds of preserved foods by the Chinese constitutes the most important cause of NPC development among these people. Preliminary data on Malays in southeast Asia, Eskimos in Alaska, and Arabs of north Africa also suggest that ingestion of preserved foods by these population groups may be responsible for their raised incidence of NPC. Regardless of race and geography, the commonest form of nasopharyngeal cancers are those that arise from the epithelial cells lining the nasopharynx. These carcinomas (commonly referred to as NPCs) constitute 75-95% of nasopharyngeal cancers in low-risk populations and virtually all nasopharyngeal cancers in high-risk populations (Ho, 1971; Sugano et al, 1978; Levine and Connelly, 1985).

Entities:  

Mesh:

Year:  1990        PMID: 2197634

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  5 in total

1.  Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area.

Authors:  Zhiwei Liu; Ellen T Chang; Qing Liu; Yonglin Cai; Zhe Zhang; Guomin Chen; Qi-Hong Huang; Shang-Hang Xie; Su-Mei Cao; Jian-Yong Shao; Wei-Hua Jia; Yuming Zheng; Jian Liao; Yufeng Chen; Longde Lin; Liming Liang; Ingemar Ernberg; Thomas L Vaughan; Hans-Olov Adami; Guangwu Huang; Yi Zeng; Yi-Xin Zeng; Weimin Ye
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

2.  Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients.

Authors:  Shuna Li; Lihua Hang; Yongming Ma; Chaoyang Wu
Journal:  J Cell Mol Med       Date:  2016-08-04       Impact factor: 5.310

3.  Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients.

Authors:  Xueming Sun; Lei Zeng; Chunyan Chen; Ying Huang; Fei Han; Weiwei Xiao; Shuai Liu; Taixiang Lu
Journal:  Radiat Oncol       Date:  2013-11-13       Impact factor: 3.481

4.  Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.

Authors:  Jun-Fang Liao; Li Ma; Xiao-Jing Du; Mei Lan; Ying Guo; Lie Zheng; Yun-Fei Xia; Wei Luo
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

5.  A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.

Authors:  Cheng-Yun Yao; Guo-Ren Zhou; Li-Jun Wang; Jian-Hua Xu; Jin-Jun Ye; Lan-Fang Zhang; Xia He; Zhen-Zhang Chen; Sheng-Fu Huang
Journal:  Radiat Oncol       Date:  2018-10-03       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.